Drug Benefit News

View Sample (PDF)

Highlights on this Page

Publication Details

Subscriptions include print and electronic issues

  • Frequency: biweekly (24 issues/year)
  • Pages: 8
  • Format: Print and PDF versions
  • ISSN: 1530-3438

  • Pub Code: NDBN-11WEB

3 Easy Ways to Order

  1. Secure Shopping Cart
  2. Call 800-521-4323
  3. Print a form to fax or mail

Drug Benefit News

A hard-hitting newsletter for health plans, PBMs, pharma companies and employers. Published biweekly, it delivers timely news and in-depth accounts of cost management strategies being employed by purchasers. Coverage includes news of soaring specialty pharmacy costs, the emerging biosimilars market, the patent cliff, generic inflation, exclusionary formularies, PBM consolidation, new adherence strategies, restrictive networks, changing reimbursement methodology and more.

Place your order through our secure shopping cart

24 issues
$639.00
4 issues
$86.00

News, Data and Business Strategies for Health Plans, Employers, PBMs and Pharma Companies

With so much at stake in the struggle to contain costs without compromising quality, it is difficult to get a clear picture of new challenges and opportunities in the pharmaceutical business, and which new strategies are working. Drug Benefit News — a biweekly newsletter focused on the issues and events with the biggest impact on pharmacy benefit management — provides news and business analysis on big-dollar topics such as:

  • The growing use of formulary exclusions by PBMs as the “generic wave” reaches its final crest.
  • Strategies to accelerate the adoption (and manage the expected flood) of biosimilars.
  • Evolving pharmacy network strategies, such as the increasing use of narrow and preferred pharmacy networks throughout the marketplace.
  • Efforts to keep pharmacy benefits affordable while meeting mandates under the ACA.
  • The impact of mergers, acquisitions and consolidations on the PBM industry and their plan sponsor clients.
  • Emerging programs to address high-cost compounded medications.
  • Trends in benefit design and copay data from AIS’s exclusive new database of prescription benefit parameters of commercial health plans.
  • The impact of star ratings and changing enrollment cycles on Medicare Part D.
  • … and other business issues of great concern to plans, PBMs and pharma companies.

As a subscriber to Drug Benefit News, you receive:

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor, Lauren Flynn Kelly.

Stay current with rapid-fire changes in the industry. Subscribe to Drug Benefit News today!

Written By

Drug Benefit News is written by an editorial team with extensive experience in pharma/health care business publishing. Editor Lauren Flynn Kelly, who served as editor of DBN from 2004 to 2005 and returned to AIS in 2011, has been covering health business issues for more than a decade. Managing Editor Angela Maas has an extensive background in editing, reporting and writing for pharma publications. She also is the managing editor of AIS’s monthly newsletter Specialty Pharmacy News. Executive Editor Jill Brown is a veteran health care reporter who brings an intelligent perspective on the forces reshaping the health care industry.

Written For

  • Health plan managers
  • Purchasers, employers, pharmacy benefit companies
  • Managers in the pharmaceutical industry

AIS Guarantee

When you subscribe to Drug Benefit News, your satisfaction is fully guaranteed. If you are not completely satisfied with the newsletter within the first 30 days, just cancel and receive a prompt 100% refund. After your first 30 days, you may cancel at any time in the year ahead and receive a full prompt refund for all unmailed issues.

Shipping Information

Electronic (PDF) versions of the newsletter are available, on the newsletter’s subscriber-only Web page, on the day of publication. Recipients should whitelist aisalert@aishealth.com to ensure delivery of the e-mail notification of new issues. Print newsletters are mailed 1st class through the U.S. Postal Service. You should receive your first issue within 5-7 business days of your order. A one-time $12 shipping and handling charge will be applied to your order.

View Sample (PDF)

Drug Benefit News

Place your order through our secure shopping cart

24 issues
$639.00
4 issues
$86.00

Renewal Center

Renew your subscriptions to AIS newsletters and looseleaf publications at the Renewal Center